# Aerobic Exercise Promotes Hippocampal Neurogenesis and Ameliorates Cognitive Dysfunction Induced by Unilateral Labyrinthectomy

**Authors:** Zhanghong Zhou, Xixi Yu, E. Tian, Zhaoqi Guo, Jingyu Chen, Jiaqi Guo, Shiyu Shi, Wandi Xu, Ni Zhai, Caijuan Qiao, Yuejin Zhang, Jun Wang, Yisheng Lu, Sulin Zhang

PMC · DOI: 10.1002/cns.70773 · CNS Neuroscience & Therapeutics · 2026-02-03

## TL;DR

Aerobic exercise can reverse cognitive impairments caused by vestibular dysfunction by promoting brain cell growth and reducing inflammation in the hippocampus.

## Contribution

This study identifies MHC class I/II-related pathways as key mediators of aerobic exercise's restorative effects on cognitive dysfunction.

## Key findings

- Aerobic exercise reversed cognitive deficits and restored hippocampal neurogenesis after unilateral labyrinthectomy.
- Transcriptomic analysis revealed normalization of gene expression in MHC class I/II and neurodevelopmental pathways following exercise.
- Pharmacological experiments confirmed that neuroinflammatory signaling modulates the cognitive benefits of aerobic exercise.

## Abstract

Vestibular dysfunction is strongly linked to cognitive impairment and dementia risk, yet its underlying mechanisms remain unclear, hindering treatment development. As a primary physical therapy intervention, aerobic exercise improves cognitive dysfunction. Thus, we investigated its potential to reverse cognitive deficits after vestibular dysfunction and explored the neurobiological mechanisms involved.

Behavioral experiments were conducted to assess the cognitive impairment induced by unilateral labyrinthectomy (UL). Immunofluorescence staining was performed to assess neural stem cell proliferation and newborn neuron maturation in the hippocampal dentate gyrus. Aerobic exercise was applied as an intervention to examine its effects on cognitive and neurogenic recovery. RNA sequencing followed by qRT‐PCR was used to characterize transcriptional changes. Pharmacological manipulation is applied to demonstrate the necessity and sufficiency of key candidate genes in mediating the exercise‐induced effects.

UL induced significant cognitive dysfunction and hippocampal neurogenesis inhibition, whereas aerobic exercise intervention reversed these impairments. Transcriptomic profiling showed that aerobic exercise normalized UL‐disrupted gene expression, with enrichment observed in MHC class I/II–related (H2‐K1, H2‐Eb1, CD74) and neurodevelopmental (Cntn5, Mid1) pathways. Pharmacological experiments established causality: inhibition of neuroinflammatory signaling with AZD1480 enhanced neurogenesis and improved cognition after UL, whereas LPS‐mediated activation of inflammation attenuated the beneficial effects of aerobic exercise.

These findings provide a novel non‐pharmacological strategy for cognitive rehabilitation, as well as early cognitive screening and exercise rehabilitation intervention for patients with vestibular disorders.

UL induced significant spatial and non‐spatial cognitive dysfunction and hippocampal neurogenesis inhibition, whereas aerobic exercise intervention effectively reversed these impairments. Transcriptomic profiling and pharmacological evidence identified MHC class I/II–related pathways (H2‐K1, H2‐Eb1, CD74) as key mediators of the restorative effects of aerobic exercise.

## Linked entities

- **Genes:** H2-K1 (histocompatibility 2, K1, K region) [NCBI Gene 14972], H2-Eb1 (histocompatibility 2, class II antigen E beta) [NCBI Gene 14969], CD74 (CD74 molecule) [NCBI Gene 972], CNTN5 (contactin 5) [NCBI Gene 53942], MID1 (midline 1) [NCBI Gene 4281]
- **Chemicals:** AZD1480 (PubChem CID 16659841)
- **Diseases:** dementia (MONDO:0001627)

## Full-text entities

- **Genes:** H2-Q (histocompatibility 2, Q region) [NCBI Gene 111462] {aka H-2Q}, Cd74 (CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated)) [NCBI Gene 16149] {aka CLIP, DHLAG, HLADG, Ia-GAMMA, Ii}, Clec1a (C-type lectin domain family 1, member a) [NCBI Gene 243653] {aka 5930406N14Rik}, Slc11a1 (solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1) [NCBI Gene 18173] {aka Bcg, Ity, Ity1, Lsh, Nramp, Nramp1}, Mki67 (antigen identified by monoclonal antibody Ki 67) [NCBI Gene 17345] {aka D630048A14Rik, Ki-67, Ki67}, Gins2 (GINS complex subunit 2) [NCBI Gene 272551] {aka 2210013I18Rik, 4833427B12Rik, Pfs2, Psf2}, H2 (histocompatibility-2, MHC) [NCBI Gene 111364] {aka H-2, MHC-II}, H2-Eb1 (histocompatibility 2, class II antigen E beta) [NCBI Gene 14969] {aka Eb, H-2Eb, H2Eb, Ia-4, Ia4}, Mid1 (midline 1) [NCBI Gene 17318] {aka 61B3-R, DXHXS1141, Fxy, Trim18}, Jak1 (Janus kinase 1) [NCBI Gene 16451] {aka BAP004, C130039L05Rik}, CNTN5 (contactin 5) [NCBI Gene 53942] {aka HNB-2s, NB-2}, NTF3 (neurotrophin 3) [NCBI Gene 4908] {aka HDNF, NGF-2, NGF2, NT-3, NT3}, Glp2r (glucagon-like peptide 2 receptor) [NCBI Gene 93896] {aka 9530092J08Rik, GLP-2}, Cntn5 (contactin 5) [NCBI Gene 244682] {aka 6720426O10Rik, A830025P08Rik, Gm507, NB-2}, Hba-a1 (hemoglobin alpha, adult chain 1) [NCBI Gene 15122] {aka Hba, Hba1, Hbat1}, Des (desmin) [NCBI Gene 13346], H2-K1 (histocompatibility 2, K1, K region) [NCBI Gene 14972] {aka H-2K, H-2K(d), H2-D1, H2-K, K-f}, CD74 (CD74 molecule) [NCBI Gene 972] {aka CLIP, DHLAG, HLADG, II, Ia-GAMMA, p33}, Ybx1 (Y box protein 1) [NCBI Gene 22608] {aka 1700102N10Rik, EF1A, MSY1, Nsep1, YB-1, dbpB}, Lyz2 (lysozyme 2) [NCBI Gene 17105] {aka Lys, Lysm, Lyzf2, Lyzs, Lzm, Lzm-s1}, MID1 (midline 1) [NCBI Gene 4281] {aka BBBG1, FXY, GBBB, GBBB1, MIDIN, OGS1}, Dcx (doublecortin) [NCBI Gene 13193] {aka Dbct}, Jak2 (Janus kinase 2) [NCBI Gene 16452] {aka Fd17}
- **Diseases:** Neuroinflammation (MESH:D000090862), AHN (MESH:D001750), locomotor impairments (MESH:D001523), autoimmune-related (MESH:D001327), Graft-versus-host disease (MESH:D006086), hyperactivity (MESH:D006948), RAM (MESH:C537826), dementia (MESH:D003704), Cognitive Dysfunction (MESH:D003072), DG (MESH:C564353), bilateral vestibular loss (MESH:D000071699), amyloid (MESH:C000718787), memory deficits (MESH:D008569), balance disorders (MESH:D009358), AD (MESH:D000544), depression (MESH:D003866), Vestibular dysfunction (MESH:D015837), neurogenic deficits (MESH:D003147), anxiety (MESH:D001007), shock (MESH:D012769), inflammation (MESH:D007249), UL (MESH:D046088)
- **Chemicals:** iodophors (MESH:D007466), OCT (MESH:C051883), DAPI (MESH:C007293), AZD1480 (MESH:C545606), TRIzol (MESH:C411644), Alexa Fluor 488 (MESH:C000711379), 5'-Bromo-2'-Deoxyuridine (MESH:D001973), poly-T (MESH:D011071), AS039 (-), sucrose (MESH:D013395), ethanol (MESH:D000431), DMSO (MESH:D004121), paraformaldehyde (MESH:C003043), Triton X-100 (MESH:D017830), Tween-20 (MESH:D011136), LPS (MESH:D008070), alcohol (MESH:D000438), pentobarbital sodium (MESH:D010424), PBS (MESH:D007854)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** C-24 C
- **Cell lines:** /6J — Homo sapiens (Human), Cutaneous melanoma, Cancer cell line (CVCL_W797)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12865327/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12865327/full.md

## References

55 references — full list in the complete paper: https://tomesphere.com/paper/PMC12865327/full.md

---
Source: https://tomesphere.com/paper/PMC12865327